Skip to content
naulon
Not checkedNot checked for notices yet.

Antimicrobial Susceptibility Test for the Determination of Resistant and Susceptible S. aureus and Enterococcus spp. Using a Multi-Channel Surface Plasmon Resonance Device

Gulsum Ucak Ozkaya, Muhammed Zeki Durak, Isin Akyar and 1 more

Diagnostics · 2019

doi:10.3390/diagnostics9040191 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

The objective of this study was to investigate the development of a surface plasmon resonance (SPR) sensor platform equipped with multiple channels for the simultaneous determination of methicillin-resistant <i>S. aureus</i> (MRSA), methicillin-susceptible <i>S. aureus</i> (MSSA) and vancomycin-resistant <i>Enterococcus</i> (VRE), and vancomycin-susceptible <i>Enterococcus</i> (VSE). Drug resistance of <i>S. aureus</i> strains against cefoxitin and <i>Enterococcus</i> strains against vancomycin were investigated both using the minimum inhibitory concentration method (MIC) assay and the SPR system equipped with single and multiple channels. The MIC values of MRSA and MSSA ranged from 32 &#181;g/mL to &gt;128 &#181;g/mL and from 1 &#181;g/mL to 4 &#181;g/mL, respectively. The MIC values of VRE and VSE were between 64 to &gt;128 &#181;g/mL and 2&#8722;4 &#181;g/mL, respectively. With the multiple-channel system, the angle shifts of MRSA, MSSA, VRE and VSE were found to be &#8722;0.030&#176; and &#8722;0.260&#176;, &#8722;0.010&#176; and &#8722;0.090&#176; respectively. The antibiotic-resistant and susceptible strains were distinguished within 3 h for <i>S. aureus</i> strains and within 6 h for <i>Enterococcus</i> strains.

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.